Moderna stock has surged nearly 600% this year on a cancer vaccine trial result that almost no one outside the trial has ...
Hosted on MSN
Pfizer is said to divest remaining stake in BioNTech
BioNTech (BNTX) ADRs lost ~5% in the premarket on Thursday after Bloomberg News reported that Pfizer (PFE) is planning to sell its remaining stake in its partner, which helped the U.S. pharma giant to ...
A Delaware federal judge on Monday rejected requests from Pfizer (PFE), BioNTech (BNTX), and Moderna (MRNA) to dismiss ...
BioNTech pivots from Covid windfall to oncology with 33 trials and $19B cash; key pumitamig data post-2028. Click for more on ...
11d
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental ...
Check out the latest Biontech Se (BNTX) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
The stock barely registered the news. BioNTech's paper changed hands at EUR 85.90 in Monday trading, a dip of 0.2%. On a ...
BioNTech SE (ISIN US09075V1026) has a USD 140.00 Berenberg target after a rise from USD 132.00. According to MarketScreener ...
BioNTech (BNTX) ADRs lost ~5% in the premarket on Thursday after Bloomberg News reported that Pfizer (PFE) is planning to sell its remaining stake in its partner, which helped the U.S. pharma giant to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results